SE · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $19.63B | $14.73B | $11.45B | $12.45B | $9.96B | $4.38B | $2.18B | $826.97M |
| Cost of Revenue | $12.69B | $9.61B | $7.23B | $7.26B | $6.06B | $3.03B | $1.57B | $812.21M |
| Gross Profit | $10.24B | $7.21B | $5.83B | $5.19B | $3.90B | $1.35B | $604.92M | $14.76M |
| Research & Development | $1.16B | $1.21B | $1.16B | $1.38B | $831.70M | $353.79M | $156.63M | $67.53M |
| Selling, General & Administrative | $1.36B | $1.27B | $1.13B | $1.44B | $987.87M | $599.71M | $385.87M | $240.78M |
| Operating Expenses | $8.26B | $6.54B | $5.61B | $6.67B | $5.48B | $2.65B | $1.50B | $1.00B |
| Operating Income | $1.99B | $662.15M | $224.78M | -$1.49B | -$1.58B | -$1.30B | -$891.23M | -$988.77M |
| Interest Expense | $33.61M | $38.34M | $41.08M | $45.40M | $136.88M | $123.84M | $48.21M | $31.30M |
| Other Income / (Expense) | $295.55M | $116.63M | $207.62M | -$13.03M | -$132.12M | -$179.91M | -$477.39M | $34.89M |
| Income Before Taxes | $2.28B | $778.78M | $432.39M | -$1.50B | -$1.72B | -$1.48B | -$1.37B | -$953.88M |
| Provision for Income Taxes | $651.08M | $321.17M | $262.68M | $168.40M | $332.87M | $141.64M | $85.86M | $4.09M |
| Net Income | $1.58B | $444.32M | $150.73M | -$1.65B | -$2.05B | -$1.62B | -$1.46B | -$961.24M |
| Basic EPS | $2.65 | $0.77 | $0.27 | -$2.96 | -$3.84 | -$3.39 | -$3.35 | — |
| Diluted EPS | $2.52 | $0.74 | $0.25 | -$2.96 | -$3.84 | -$3.39 | -$3.35 | — |
| Basic Shares Outstanding | 595.02M | 574.97M | 566.61M | 558.12M | 532.71M | 477.26M | 436.60M | — |
| Diluted Shares Outstanding | 638.23M | 604.71M | 594.41M | 558.12M | 532.71M | 477.26M | 436.60M | — |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $3.23 | $3.14 | $3.32 | 2 | ↑0 ↓0 |
| Dec 2027 | $4.74 | $4.35 | $5.14 | 2 | ↑0 ↓0 |
| Dec 2028 | $6.16 | $5.38 | $6.95 | 2 | ↑0 ↓0 |